{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:27:35Z","timestamp":1760189255815},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1097\/dad.0b013e31824d689c","type":"journal-article","created":{"date-parts":[[2012,4,25]],"date-time":"2012-04-25T08:00:00Z","timestamp":1335340800000},"page":"626-631","source":"Crossref","is-referenced-by-count":7,"title":["Alpha-Interferon Secreting Blastic Plasmacytoid Dendritic Cells Neoplasm"],"prefix":"10.1097","volume":"34","author":[{"given":"Tony","family":"Petrella","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genevi\u00e8ve","family":"Herv\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Bonnotte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Girodon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John Andrew","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Baptiste","family":"Bour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Lebon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francine","family":"Mugneret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Callier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-9-20210202","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":". WHO-EORTC classification for cutaneous lymphomas.","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"R4-9-20210202","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1309\/GJWNPD8HU5MAJ837","article-title":". Blastic NK-cell lymphomas (agranular CD4CD56 hematodermic neoplasms): a review.","volume":"123","author":"Petrella","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"R5-9-20210202","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1182\/blood-2007-10-117531","article-title":". Novel markers of normal and neoplastic human plasmacytoid dendritic cells.","volume":"111","author":"Marafioti","year":"2008","journal-title":"Blood"},{"key":"R6-9-20210202","first-page":"210","article-title":"Tumoral aspects of plasmacytoid dendritic cells: What do we know in 2009 Autoimmunity.","volume":"43","author":"Petrella","year":"2010","journal-title":""},{"key":"R7-9-20210202","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/PAP.0b013e3181bb6bc2","article-title":"Plasmacytoid dendritic cells: physiologic roles and pathologic states.","volume":"16","author":"Jegalian","year":"2009","journal-title":"Adv Anat Pathol"},{"key":"R8-9-20210202","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.biochi.2007.04.015","article-title":"Interferon-induced Mx proteins in antiviral host defense.","volume":"89","author":"Haller","year":"2007","journal-title":"Biochimie"},{"key":"R9-9-20210202","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.1128\/JVI.02433-07","article-title":". Plasmacytoid dendritic cell dynamics and alpha interferon production during Simian immunodeficiency virus infection with a nonpathogenic outcome.","volume":"82","author":"Diop","year":"2008","journal-title":"J Virol"},{"key":"R10-9-20210202","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00000478-199902000-00001","article-title":". CD4 CD56 cutaneous neoplasms: a distinct hematological entity Groupe Francais dEtude des Lymphomes Cutanes (GFELC).","volume":"23","author":"Petrella","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"R11-9-20210202","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1182\/blood.V99.11.4154","article-title":". CD4(), CD56() DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Francais de Cytogenetique Hematologique.","volume":"99","author":"Leroux","year":"2002","journal-title":"Blood"},{"key":"R12-9-20210202","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1182\/blood-2006-04-018143","article-title":". Gene-expression profiling and array-based CGH classify CD4CD56 hematodermic neoplasm and cutaneous myelomonocytic leukemia as distinct disease entities.","volume":"109","author":"Dijkman","year":"2007","journal-title":"Blood"},{"key":"R13-9-20210202","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/leu.2008.359","article-title":". Recurrent genomic aberrations combined with deletions of various tumour suppressor genes may deregulate the G1S transition in CD4CD56 haematodermic neoplasms and contribute to the aggressiveness of the disease.","volume":"23","author":"Jardin","year":"2009","journal-title":"Leukemia"},{"key":"R14-9-20210202","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/jid.2009.369","article-title":". Alterations of the cell-cycle inhibitors p27(KIP1) and p16(INK4a) are frequent in blastic plasmacytoid dendritic cell neoplasms.","volume":"130","author":"Wiesner","year":"2010","journal-title":"J Invest Dermatol"},{"key":"R15-9-20210202","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.1182\/blood-2011-03-337501","article-title":". Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion.","volume":"118","author":"Lucioni","year":"2011","journal-title":"Blood"},{"key":"R16-9-20210202","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.semcancer.2005.01.008","article-title":"ETV6: a versatile player in leukemogenesis.","volume":"15","author":"Bohlander","year":"2005","journal-title":"Semin Cancer Biol"},{"key":"R17-9-20210202","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1532\/IJH97.04116","article-title":". A novel plasmacytoid dendritic cell line, CAL-1, established from a patient with blastic natural killer cell lymphoma.","volume":"81","author":"Maeda","year":"2005","journal-title":"Int J Hematol"},{"key":"R18-9-20210202","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1182\/blood.V97.10.3210","article-title":". Identification of a leukemic counterpart of the plasmacytoid dendritic cells.","volume":"97","author":"Chaperot","year":"2001","journal-title":"Blood"},{"key":"R19-9-20210202","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2141.1987.tb06142.x","article-title":". Chronic and subacute myelomonocytic leukaemia in the adult: a report of 60 cases with special reference to prognostic factors.","volume":"65","author":"Fenaux","year":"1987","journal-title":"Br J Haematol"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0b013e31824d689c","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:17:39Z","timestamp":1620951459000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000372-201208000-00009"}},"subtitle":["A Case Report With Histological, Molecular Genetics and Long-Term Tumor Cells Culture Studies"],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0b013e31824d689c","relation":{},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}